<p>Mark Schoenberg, Chief Medical Officer of Urogen Pharma Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Urogen Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-035821), on November 20, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

URGN

<p>Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd., has sold common shares of the company. This event was reported via EDGAR by UroGen Pharma Ltd. on November 20, 2025. The information is for informational purposes and not financial advice.</p>

UroGen Pharma Chief Medical Officer Mark Schoenberg Sells Common Shares